Publications Database

Campbell M. et al. (1972)

Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children.

Journal of Autism and Developmental Disorders

2(4),

Read Abstract (New Window)

Hazell P. (2007)

Drug therapy for attention-deficit hyperactivity disorder-like symptoms in autistic disorder.

Journal of Paediatrics and Child Health

43(1), pp. 19-24

Read Abstract (New Window)

Mahajan R. et al. (2012)

Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders.

Pediatrics

130 S125-138

Read Abstract (New Window) Read Full (New Window)

National Institute for Health and Clinical Excellence (2000)

Methylphenidate, atomoxetine and dexamfetamine for the treatment of attention deficit hyperactivity disorder in children and adolescents (including a review of guidance TA13)

London: National Institute for Health and Clinical Excellence

Read Full (New Window)

Nickels K. et al. (2008)

Stimulant medication treatment of target behaviors in children with autism: a population-based study.

Journal of Developmental and Behavioral Pediatrics

29(2), pp. 75-81

Read Abstract (New Window) Read Full (New Window)

American Society of Health-System Pharmacists (2007)

Dextroamphetamine.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

Stigler K. A. et al. (2004)

A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

14(1), pp. 49-56

Read Abstract (New Window)

Tsai L. Y. (1999)

Psychopharmacology in autism.

Psychosomatic Medicine

61(5), pp. 651-665

Read Abstract (New Window) Read Full (New Window)